Tavr 2.0
Research payments
$456,652
Through program year 2023, $456,652 in research payments was reported against Tavr 2.0, across 216 payments.
- Paid by (largest first)
- Medtronic Vascular, Inc.; Medtronic, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $13,970 | 10 |
| 2022 | Research | $120,874 | 55 |
| 2021 | Research | $92,486 | 63 |
| 2020 | Research | $79,093 | 43 |
| 2019 | Research | $150,229 | 45 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Jae Oh Rochester, MN Named on 24 payments
- Peter Tadros Kansas City, KS Named on 12 payments
- Neal Kleiman Houston, TX Named on 10 payments
- Michael Reardon Houston, TX Named on 10 payments
- John Brown Morristown, NJ Named on 9 payments
- George Zorn Kansas City, KS Named on 7 payments
- Jonathan Waks Boston, MA Named on 7 payments
- Steven Yakubov Columbus, OH Named on 7 payments
- Jeffrey Veluz Allentown, PA Named on 7 payments
- Abeel Mangi New Haven, CT Named on 6 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.